). As a first attempt to investigate pathway-level associations, our results suggest a role of specific DNA repair genes/pathways in specific upper aerodigestive tract cancer sites.
Introduction
Cancers of the upper aerodigestive tract (UADT), comprising the oral cavity, pharynx, larynx and esophagus, are among the most common cancers worldwide with nearly 1 million new cases and 700 000 deaths occurring each year (1) . UADT cancers are strongly related to tobacco smoking and alcohol consumption in developed countries (2) . Other associated factors include human papillomavirus infections and familial history of UADT cancers (3, 4) . Thus, DNA repair genes could play a key role in UADT cancer susceptibility. Indeed, in response to DNA damage produced by exogenous mutagens, such as those contained in tobacco smoke, cells activate multiple signaling pathways for the efficient and accurate repair of lesions, thus maintaining genome stability (5) . To date, candidate gene studies have tested only a very small number of DNA repair gene polymorphisms in relation to UADT cancer risk with very few consistent findings (6, 7) . Moreover, no studies have investigated the association of sets of single nucleotide polymorphisms (SNPs) within DNA repair pathways or genes with UADT cancer risk. To identify such sets of SNPs involved in UADT cancers, we used a targeted pathway and gene-specific approach on pooled genome-wide association studies (GWAS) data. The SNP-set approach has two advantages over the SNP-by-SNP approach. First, it decreases the number of tests performed, thus improving the power of detecting an associated gene or pathway. Second, it is a powerful approach to identify genes or pathways that harbor multiple SNPs with small effects, which are more difficult to detect using the conventional GWAS SNP-by-SNP approach. This approach provides additional insight into the genetic architecture of UADT cancers. Here, we report the comprehensive analysis of the association between 13 DNA repair pathways, comprising 212 genes, and UADT cancer risk based on GWAS data from 5075 European individuals.
Materials and methods

Study population
To study DNA repair pathways, we pooled two European genome-wide UADT case-control samples from the International Head and Neck Cancer Epidemiology consortium: the Alcohol-Related Cancers And Genetic susceptibility in Europe (ARCAGE) (8) and Central Europe (CE) (9) studies comprising samples from nine and five countries, respectively. After the initial quality control (QC) procedures done for the GWAS (see table S1 in ref. 10) , clinical and epidemiological information were available for 2091 UADT cancer cases (1368 and 723 from ARCAGE and CE, respectively) and 3513 controls (1313 and 2200 from ARCAGE and CE, respectively).
Further individual-based QC first excluded 65 individuals because they were outliers on a principal components analysis performed on a pruned set of 12 701 genome-wide SNPs using smartPCA (11) . Then, an additional 39 cases with unknown cancer site were excluded.
Finally, 425 individuals (68 cases and 357 controls) with incomplete information on lifetime tobacco smoking and/or alcohol consumption were removed. Tobacco smoking was then categorized as never, light and heavy smoking. The limit between the light and heavy smoking categories was the observed median of the lifetime tobacco smoking in controls who had ever smoked (25 pack-years). Alcohol status was categorized into three classes (light, moderate and heavy) using the tertiles of average lifetime ethanol consumption in controls (6 and 23 ml/day).
Pathway definition and genotype QC
To define DNA repair pathways, we first collated a list of 212 autosomal genes from the Gene Ontology database, as coding for DNA repair proteins in a broad sense, i.e. proteins involved in the classical DNA repair, in human diseases sensitive to DNA-damaging agents or in cell cycle regulation (CCR). These 212 genes were then grouped into 13 non-overlapping DNA repair pathways as in Kazma et al. (12) . However, it is clear that some repair proteins may be acting in several pathways according to the type of DNA lesions, the state of the cell cycle or the cell type. In that case, the gene was allotted to the repair pathway where it is the most often operating.
Then, we compiled a list of 1791 SNPs located inside or within 20 kb flanking regions of these genes and present on the Illumina Sentrix HumanHap300 Bead Chips, on which both ARCAGE and CE studies were genotyped at the Centre National de Génotypage (Evry, France) (13, 14) . Finally, genotypes of all individuals at these SNPs were retrieved.
The genotype-based QC excluded 52 SNPs with a call rate <0.95, 6 SNPs with significant departure from Hardy-Weinberg proportions in controls (P < 3 × 10 −5 ) and 53 SNPs with a minor allele frequency in controls <0.05.
Statistical analysis
To study the association of DNA repair pathways or genes with UADT cancer risk, we used the SNP-set kernel association test (SKAT) v0.83 (15), Abbreviations: ARCAGE, Alcohol-Related Cancers And Genetic susceptibility in Europe; CCR, cell cycle regulation; CE, Central Europe; GWAS, genome-wide association studies; ICL, interstrand crosslink; POL, polymerase; QC, quality control; SKAT, SNP-set kernel association test; SNP, single nucleotide polymorphism; UADT, upper aerodigestive tract.
implemented in R v2. 15.2 (16) . Briefly, SKAT is a kernel-machine logistic regression that takes into account the joint effect of all SNPs in a set (defined as belonging either to a gene or to a pathway in our study). SKAT aggregates individual score statistics of SNPs and provides a global P-value for the analyzed SNP-set taking into account the dependency between the SNPs within a set. Note that the SKAT approach does not require any adjustment for the gene size, SNP number or linkage disequilibrium patterns.
For all analyses, we chose the kernel that models identity-by-state, i.e. the number of alleles shared by a pair of individuals. This kernel is the most powerful option when epistatic effects may be present (17) . Also, all analyses adjusted for age, gender, lifetime tobacco smoking, alcohol consumption and study centers. Adjustment on study center was performed by including the coordinates of the first two principal components from the principal components analysis, a good indicator of population of origin. Indeed, it has been shown that the North/South and East/West gradients are well captured by these two components (18) . Because SKAT requires no missing data, missing genotypes at a given SNP were imputed with the most frequent genotype category.
The analysis strategy consisted of three successive steps.
In step 1, we tested the association of the 13 pathway SNP-sets with UADT cancer risk. In step 2, we tested the association of genes belonging to pathways that were significant in step 1 with UADT cancer risk. To account for multiple testing, we used the Dunn-Sidak correction for the number of pathways tested in step 1 and for the number of genes within a pathway tested in step 2. Finally in step 3, to determine the SNPs that contribute to the association signal of each significant gene from step 2, we performed a forward stepwise regression. Starting with the initial model that contained only the adjustment covariates, we added SNPs one by one, using the Akaike Information Criterion, at a level of 5%, for model selection.
This procedure was applied for each of the three cancer sites (oral cavity/ pharynx, larynx and esophagus) and for all sites combined.
Results
After QC procedures, our study population included 3121 controls and 1954 cancer cases, distributed into 989 cancers of the oral cavity/pharynx (441 oral cancers, 451 pharyngeal cancers and 97 unspecified or unclassifiable), 660 cancers of the larynx and 305 esophageal squamous cell carcinomas. Demographic characteristics and distribution of smoking and alcohol consumption are provided in Table I . UADT cancer cases were more often males [1 degree of freedom (df) chi-square test, P = 7.2 × 10 −10 ], heavy tobacco smokers (2df chi-square test, P = 1.3 × 10 −122 ) and heavy alcohol consumers (2df chi-square test, P = 3.3 × 10 −70 ) than controls.
The polymerase (POL) pathway is the only pathway significant for all UADT cancer sites combined (P = 5.38 × 10 −4 , P-corrected = 6.97 × 10 −3 after correction for 13 tests) and for oral cavity/pharynx cancer (P = 3.49 × 10 −3 , P-corrected = 4.45 × 10 −2
). Moreover, the CCR pathway is the only pathway significant for esophagus cancer (P = 1.15 × 10 −3 , P-corrected = 1.48 × 10 −2 ). In contrast, none of the investigated pathways is significant for larynx cancer (Table II) .
The POL pathway and oral cavity/pharynx cancers The signal of the POL pathway for all UADT cancer sites combined is entirely driven by its association with oral cavity/pharynx cancer because it is no more significant when analyzing all sites excluding oral cavity/pharynx cancer (P-corrected = 0.98). Therefore, in step 2 (gene analysis), we only focused on the association of oral cavity/ pharynx cancer with genes belonging to POL.
The POL pathway includes 21 genes, of which HELQ is the only significantly associated gene (P = 5.83 × 10 −4 , P-corrected = 0.012 after correction for 21 tests; Table III ). The association with the POLN gene is also borderline significant (P = 0.003, P-corrected = 0.06), but the POL pathway signal is entirely due to the association with HELQ because the association with POL is no more significant when HELQ is excluded from the model (P-corrected = 0.41).
Forward stepwise regression of the eight SNPs located in HELQ showed that a model including rs1494961 only significantly explains the association with oral cavity/pharynx cancer (P = 2.65 × 10 −4 ). The risk allele of rs1494961 is the minor allele C (frequency of 0.53 and 0.48 in cases and controls, respectively) and has an allelic odds ratio for oral cavity/pharynx cancers of 1.22 (95% confidence interval 1.10-1.37).
The CCR pathway and esophagus cancer
The CCR pathway comprises 22 genes, of which CSNK1E is the only gene significantly associated with esophagus cancer (P = 4.82 × 10 −4 , According to pack-years of smoking, never (0 pack-years), light (≤25 pack-years) and heavy (>25 pack-years). d According to the lifetime consumption: light (≤6 ml/day), moderate (6-23 ml/day) and heavy (>23 ml/day).
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P-corrected = 1.05 × 10 −2 after correction for 22 tests; Table IV ). This association with CCR is no longer significant after removing the CSNK1E gene from the model (P-corrected = 0.20). Forward stepwise regression of the 11 SNPs in CSNK1E showed that the association signal is significantly explained by a model that includes three SNPs: rs1534891 (P = 1.27 × 10 ). In all three cases, the risk allele is the major allele (Table V) . None of these SNPs are in linkage disequilibrium with each other (r 2 = 0). Finally, the same procedure was carried out on both data sets, ARCAGE and CE, separately to check whether the results were consistent. The pathway and gene-based analyses led to the same significant results in the ARCAGE data set. However, they did not reach significance in the CE data sets, although the corresponding signals were ranked among the top three signals among pathways and genes (data not shown). This probably results from a lack of power due to the smaller size of the CE data set.
Discussion
Using an innovative approach testing SNP-sets within DNA repair pathways, our study comprehensively deciphers the role of genetic variants in DNA repair pathways in upper aerodigestive tract cancers, using a large sample of cases and controls of European descent.
First, we showed a role of the HELQ gene on chromosome 4q21, belonging to the POL pathway in the susceptibility to cancers of the oral cavity and pharynx. The most significant signal was observed for the SNP rs1494961, which is a missense mutation I306V on the second exon of HELQ. The association with this SNP was previously reported both in the discovery and replication samples of a recent genome-wide association study of UADT cancers, within the International Head and Neck Cancer Epidemiology consortium (10) . The association with rs1494961 was initially found in the analysis of UADT cancers, irrespective of site, and with and without adjusting for tobacco and/or alcohol. Stratification by cancer sites showed a significant association with oral cavity and oropharynx cancers, but not with larynx or esophagus cancers. The analysis of nine lung cancer studies by the same authors also showed the role of rs1494961, although not reaching the genome-wide significance level, suggesting its implication in other tobacco-related cancers. The same SNP rs1494961 was also reported as associated in a study of 2139 esophageal squamous cell carcinoma cases and 2273 controls from China, with an allelic odds ratio of 1.15, which is of similar magnitude to that of our study, after adjusting for smoking and drinking status (both coded as never/ever) (19) . Another study of 575 head and neck cancer cases and 676 controls from the Boston area (USA) (20) suggested an interaction between this same SNP and tobacco smoking on cancer risk. In addition, a neighboring intronic SNP in the FAM175A gene, rs13115704, which is in linkage disequilibrium with rs1494961, has also been found associated with esophageal squamous cell carcinoma in a sample of 1942 cases and 2111 controls from China (21) . The lack of evidence for a role of HELQ in our 305 esophageal cancer cases may be due to limited power.
The HELQ gene codes a single-stranded DNA-dependent adenosine triphosphatase and a DNA helicase that translocates in the 3ʹ-5ʹ direction (22) . It has been proposed that HELQ could open up the parental DNA at a blocked DNA replication fork allowing the loading of subsequent factors for DNA repair processing and restart of DNA synthesis (23) . Disruption of HELQ leads to enhanced sensitivity to DNA interstrand crosslinks (ICLs) indicating that HELQ intervenes in DNA repair and cell cycle signaling in response to ICL. Its direct interaction with RAD51 suggests a role in homologous recombination at damaged replication forks (24, 25) . Because ICL can be induced by both tobacco smoking and alcohol consumption, an abnormal function of HELQ could inhibit ICL repair and facilitate tobacco-and alcohol-induced cancers. All together, these findings suggest the relevance of HELQ in smoking-and/or alcohol-induced cancers.
Second, we showed the role of three SNPs located on chromosome 22q13 in the vicinity of the gene CSNK1E involved in the CCR pathway, specifically in esophageal cancer. The CSNK1E gene codes a serine/ threonine kinase, a member of the casein kinase I family. These kinases have been shown to control cytoplasmic and nuclear processes via phosphorylation. In particular, these kinases phosphorylate PERIOD, a circadian rhythm protein and may be involved in phosphorylation of topoisomerase II α (26). Indeed, CSNK1E belongs to the set of genes involved in the circadian clock. Although it is difficult to put forward a possible hormonal role in esophageal cancers, some authors (27) have reported that circadian genes are also involved in regulating cancerrelated biological pathways such as cell proliferation and apoptosis by controlling the expression of tumor suppressor genes, cell cycle genes, and genes encoding caspases and transcription factors. Mutations or abnormal expression of CSNK1E have been found in breast cancers (28) , ovarian cancers (29) , leukemia, prostate and salivary carcinoma (30) .
The regulation of the cell cycle is of major interest for both normal and tumoral cells because it allows the cell to survive faithfully or not and to give rise to progeny. Interestingly, the DNA POLs are obligatorily associated to cell cycle because both the replicative POLs, which replicate the whole cellular genome, and the translesion POLs, which are used to tolerate DNA damage, are necessary to fulfill a complete S-phase and therefore to allow the completion of the cell cycle. It is, finally, not so surprising that these two processes are both associated with cancer risk.
The DNA repair pathways studied were designed to be non-overlapping. Categorizing genes into non-overlapping pathways is challenging as several proteins play roles in multiple pathways. One way to overcome this issue would be to use a system biology approach with weighting factors assigned to genes coding for such proteins. Nonetheless, such an approach would still be dependent on the criteria used to classify genes and determine weights. Consequently, analyzing pathways is sensitive to this arbitrary choice and a different classification could lead to different results.
Interestingly, if we had chosen a SNP-by-SNP approach for this analysis, none of the SNPs in HELQ and CSNK1E would have reached significance after correcting for the total number of SNP tests. This demonstrates the value of our SNP-set approach in the context of this study population with a limited number of cases and controls.
In conclusion, as a first attempt to investigate a pathway-level association, our results suggest a role of specific DNA repair genes/pathways in specific UADT cancer sites. a Per minor allele odds ratio using major allele as reference.
